Darwin Global Management, Ltd. Relay Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $3.56 Million - $4.55 Million	-119,775 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $18.2 Million - $25.3 Million	-662,696 Reduced 84.69%	119,775 $4.38 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $25.4 Million - $48.1 Million	782,471 New	782,471 $27.1 Million

181

127M

16.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $702M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.